5-27-2022Cross-posted from NIAID Now (May 18, 2022)Today marks the 25th anniversary of the first HIV Vaccine Awareness Day. Although tremendous progress has been made o…
3-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID)…
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in …
12-8-2021National Influenza Vaccination Week, observed December 5–11 this year, is a call to all Americans 6 months and older to get their annual flu vaccine. Flu is a…
9-29-2021Cross-posted from CDC NewsroomToday, CDC issued an urgent health advisory to increase COVID-19 vaccination among people who are pregnant, recently pregnant (inc…
9-1-2021Cross-posted from NIAID newsroom No Safety Concerns Found in Imbokodo Sub-Saharan Africa StudyAn investigational HIV vaccine tested in the “Imbokodo” clinic…
5-18-2021Cross-posted from NIAID Now blogWhile implementation of highly effective HIV treatment and prevention tools has reduced the HIV pandemic worldwide, development …
4-20-2021April 16, 2021Dear Colleague,The COVID-19 pandemic has exposed the egregious and long-standing inequities that exist across the United States—inequities that …
3-9-2021In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach shared highlights from HIV research presented at the 2021 virtual Conference on Retrovi…